Coherus Oncology CHRS
NASDAQ CHRS
$0.77 +0.02 (+2.82%)
At close: Nov 6, 2026 · 4:00 PM EST

Coherus Oncology (CHRS) Net of Acquisitions & Divestments (2014)

Updated

Analysis

Coherus Oncology (CHRS) Net of Acquisitions & Divestments (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn -887.00 Mn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 17.15 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -10.59 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -630.00 Mn
5 Novartis Ag 315.51 Bn 288.75 Bn - 42.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Coherus Oncology 119.30 Mn -516.84 Mn 10.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 2.33 Mn
API Access

Coherus Oncology Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=CHRS&period=max&api_key=YOUR_API_KEY